Tomonori Mizutani

6PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 11, 2026
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case series.

Tomoaki Nakamura, Tatsuya Yoshida, Akihiko Yoshida

|Jul 22, 2024
Geriatric oncology in the most aged societies.

Tomonori Mizutani

|Mar 12, 2024
Promising Objective Response Rates and Progression-Free Survival but Modest Overall Survival in the TAB Study.

Naohiro Okano, Tomonori Mizutani, Shuichi Hironaka

|Jan 26, 2023
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy.

Hiroto Ishiki, Yuichiro Kikawa, Mitsumi Terada

Pageof 1